The pioneering AbiProt® technology is a completely new concept in antibody discovery. It has proven capabilities to deliver antibodies against clinically meaningful targets, previously undruggable with conventional antibody technologies. AbiProt® is a scalable breakthrough innovation with potential to impact the lives of millions of patients. Some call it a revolution, we call it magic.About AbiProt®
We focus on developing new antibody medicines in pain. These conditions are in strong need of effective therapies that can only be solved by breakthrough science and innovation. The AbiProt® technology has proven to deliver precision antibodies against clinically meaningful targets.
We are a team of pharma professionals and young talent with strong scientific and business acumen. We have a proven track record of bringing drugs to the market, excellence in science, and product development. We are devoted to change the life of patients through innovation.About our Team
Recent newsMore news
15 January 2024 News
Oblique Therapeutics presents at Redeye
28 November 2023 News
17 November 2023 News